28 results on '"Moliterno, David"'
Search Results
2. Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
3. Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)
4. Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)
5. Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non–ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)
6. Usefulness and Safety of Vorapaxar in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial)
7. Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)
8. Meta-Analysis of Long-Term Outcomes for Drug-Eluting Stents Versus Bare-Metal Stents in Primary Percutaneous Coronary Interventions for ST-Segment Elevation Myocardial Infarction
9. Six-Month Follow-Up of Patients With In-Hospital Thrombocytopenia During Heparin-Based Anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] Registry)
10. Contribution of Bleeding and Thromboembolic Events to In-Hospital Mortality Among Patients With Thrombocytopenia Treated With Heparin
11. Outcome of Multivessel Coronary Intervention in the Contemporary Percutaneous Revascularization Era
12. Achieving tissue-level perfusion in the setting of acute myocardial infarction
13. Differences between men and women in the management of unstable angina pectoris (the Guarantee Registry)
14. Meta-Analysis Comparing Reported Frequency of Atrial Fibrillation After Acute Coronary Syndromes in Asians Versus Whites
15. Association of Height With Outcomes in Patients With Acute Myocardial Infarction Receiving Reperfusion Therapy
16. Association of race with complications and prognosis following acute coronary syndromes
17. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention
18. Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention
19. Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation
20. Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients ≤40 years old
21. Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization
22. Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)
23. Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes—observations from the TARGET trial
24. Correlation of Point-of-Care ecarin clotting time versus activated clotting time with bivalirudin concentrations
25. Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition
26. Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab
27. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction
28. Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.